Pradaxa Side Effects Lawsuits Filed in Federal Court

Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country.

Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the first federal lawsuits to be filed in connection with the drug.

Pradaxa (dabigatran) was first approved by the U.S. Food and Drug Administration in 2010 to prevent blood clots and strokes in patients who suffer from a heart rhythm defect known as atrial fibrillation (AF). The drug was designed to be a safer alternative to other blood-thinning medications on the market but has become the subject of scrutiny after research studies have linked Pradaxa to an increased risk of serious bleeding events.

One of the lawsuits filed against Boehringer blames Pradaxa for the wrongful death of a Tennessee woman who began using the drug in January 2011 to treat her atrial fibrillation. According to the woman’s daughter, who filed the suit, Pradaxa caused her to suffer a massive gastrointestinal bleed, which resulted in her death less than three months after she began taking the drug.

In November 2011, Boehringer acknowledged that as many as 260 deaths worldwide had been linked to Pradaxa. The FDA issued an updated safety communication in December 2011, warning patients and health care providers about the potential link between the drug and bleeding risk. The FDA did, however, state that Pradaxa’s benefits outweighed the risk and advised patients to seek medical advice before discontinuing its use.

Just last week, a group of hematologist from New Zealand and Australia announced that a two-month investigative review uncovered 78 cases of bleeding related to Pradaxa, with 44 of these patients experiencing major bleeding events. The researchers, who discussed their findings in a letter to the editor published in the March 1 issue of the New England Journal of Medicine, suggested that at least one patient may have died in connection with prolonged internal bleeding caused by Pradaxa.

Patients who suffered a serious bleeding event or other complications after using Pradaxa are urged to complete a MedWatch form by visiting the Food and Drug Administration’s website. It is also recommended that you contact an experienced Pradaxa injury attorney to discuss your legal rights.

Attorney Jeffrey Nadrich believes that these lawsuits are just the first of many that will likely be filed in connection with injuries or deaths caused by Pradaxa. Nadrich & Cohen LLP offers confidential, no-cost consultations to Pradaxa users who believe they were harmed by the drug. Help is available by calling 1-800-722-0765 or by completing an online case evaluation form at www.personalinjurylawcal.com.

Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California. The firm specializes in handling mass tort actions and representing individuals in cases involving pharmaceutical companies, medical device makers and other product manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.

In addition to handling Pradaxa side effects claims, Nadrich & Cohen, LLP investigates cases involving Actos, Yaz, Vaginal Mesh, DePuy ASR Hips, Zimmer Hips, Wright Conserve Hips, Stevens-Johnson Syndrome, Reflex Sympathy Dystrophy, Fen Phen and PPH, Depakote and Reglan.

Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com

This release was published on openPR.